Завершено
Фаза III
Беларусь
CNTO148 (голимумаб) · Janssen Biologics B.V.
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects With Active Psoriatic Arthritis